Enter your login e-mail to the account
Search
Search parameters
Search results
- Iatrogenic, drug‑ induced depressions
PharmDr. Jana Hroudová, Ph.D.
(2/2020, Review articles ) - Rational use of psychotropic drugs in oncology – selected indications, interactions, tips for practice
PharmDr. Jana Gregorová, MUDr. Petra Holečková, Ph.D., MBA
(4/2017, Review articles ) - Psychopharmacology in oncology, possibility influence of pain
MUDr. Ludmila Tirayová
(5/2001, Review articles ) - Depression in cancer patients
MUDr. Radkin Honzák, CSc.
(1/2012, Councils in psychiatry )
- Recent achievements in targeted treatment of advanced non-small cell lung cancer with rare RET, MET, BRAF and NTRK gene alterations
MUDr. Róbert Godál
(1/2021, Main topic ) - PHARMACOECONOMICAL EVALUATION OF ONCOLOGY DRUGS – DIFFICULTIES AND POSSIBLE SOLUTIONS
doc. MUDr. Ján Bielik, CSc., PharmDr. Dominikk Tomek, MPH
(1/2008, Review articles ) - News in the treatment of lung cancer
doc. MUDr. Peter Beržinec, CSc.
(4/2012, Review articles ) - ACCES TO INNOVATIVE DRUGS IN ONCOLOGY IN SLOVAKIA – COMPARISON WITH THE WORLD
PharmDr. Dominik Tomek, MPH
(1/2008, Review articles ) - PHARMACOECONOMICS – ITS POSITION IN DRUG POLICY
prof. RNDr. Viliam Foltán, CSc., Mgr. Veronika Dubajová, PharmDr. Tomáš Tesař, PHD, MBA
(1/2008, Review articles ) - PHARMACOECONOMICS OF ONCOLOGIC TREATMENT FORM THE POINT OF VIEW OF HEALTH INSURANCE COMPANY
MUDr. Alexander Paluch, MUDr. Lucia Vitárius, MPH
(1/2008, Review articles ) - The growth factors in oncology
MUDr. Ján Gyárfáš
(4/2012, Main topic ) - Waldenström’s macroglobulinemia in 2016: in order to optimize immunochemotherapy minimizing side effects
MUDr. Michal Kaščák, Mgr. Zuzaná Kufová, Mgr. Kateřina Growková, prof. MUDr. Roman Hájek, CSc.
(5/2016, Spectrum ) - Pediatric oncology on the verge of 21. century: perspectives, aims and future visions
as. MUDr. Viera Bajčiová, CSc.
(1/2007, Review articles ) - Current treatment options of transplant-ineligible patients with multiple myeloma
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(3/2013, Focus ) - CURRENT ALTERNATIVES FOR SECOND LINE CHEMOTHERAPY OF RECURRENT CIS-PLATIN REFRACTORY EPITHELIAL OVARIAN CANCER
MUDr. Radovan Barilla
(2/2006, Review articles ) - Publikujeme v zahraničí
(1/2011, Information & comments ) - CARDIOVASCULAR COMPLICATIONS OF SELECTED ANTICANCER AGENTS – NEW INSIGHTS INTO PATHOGENESIS AND DIAGNOSTICS
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Silvia Cingelová
(2/2008, Review articles ) - Originator and generics drugs and oncologic practice
prof. PharmDr. Ján Kyselovič, CSc.
(6/2013, Review articles ) - Zaujímavosti z literatúry
doc. MUDr. Peter Beržinec, CSc.
(1/2009, Information & comments ) - Review of of pharmacotherapy of metastatic melanoma
MUDr. Slavomír Urbanček, PhD.
(6/2016, Main topic ) - Immunooncology and immunotherapy: principles of function and dysfunction of immune system in malignancies
MUDr. Katarína Rejleková, PhD.
(1/2023, Main topic ) - LHRH analogs in treatment of breast cancer
MUDr. Ján Rajec, PhD., MUDr. Lucia Dzurillová
(3/2015, Review articles ) - Treatment of ALK-rearranged non-small cell lung cancer
MUDr. Zuzana Pribulová
(6/2015, Main topic ) - Cancer drug consumption 2012-2015
Ing. Tomáš Mesároš, MBA, JUDr. Ing. Štefan Mesároš, PhD.
(2/2017, Main topic ) - Criteria of the oncology drugs categorisation process on use of the principle „the value for money“ from the point of view of expected benefits
MVDr., Mgr. Peter Mrva, MPH
(2/2017, Main topic ) - Quantification of the impact of cost-effectiveness threshold on cancer drugs reimbursement in Slovakia
RNDr. Mária Pšenková, MPH, Mgr. Marek Psota, PhD., Ing. Martin Suchanský, doc. RNDr. Martina Ondrušová, PhD., MPH
(2/2017, Main topic ) - New insights into the pathophysiology of multiple myeloma
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(1/2013, Editorial ) - Publikujeme v zahraničí
(6/2015, Information & comments ) - Cardiotoxicity of targeted cancer therapy
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Mária Rečková
(1/2013, Main topic ) - NEW ANTIMICROBIAL SUBSTANCES AND THEIR IMPORTANCE FOR ONCOLOGY PATIENTS – OVERVIEW
h.doc. MUDr. Ľuboš Drgoňa, CSc.
(4/2006, Review articles ) - Current opinions on chemotherapy for prostate cancer
doc. MUDr. Ján Ľupták, PhD.
(3/2011, Review articles ) - Cancer drug consumption in Slovakia and its economic impact – development and trends
prof. RNDr. Viliam Foltán, CSc., PharmDr. Veronika Dubajová, Mgr. Katarína Gatialová , Mgr. Katarína Bellová
(3/2011, Review articles ) - Systemic treatment of bladder cancer – neoadjuvant, adjuvant and palliative chemotherapy
MUDr. Branislav Bystrický, MUDr. Filip Kohútek, MUDr. Peter Kohútek, MUDr. Tomáš Sedláček
(3/2016, Review articles ) - Nano-particle nab-paclitaxel in treatment of metastatic breast cancer
MUDr. Jozef Dolinský, MUDr. Radovan Barilla, PhD.
(4/2011, Review articles ) - Possibility of applying probiotics in oncology
prof. MUDr. Ľudovít Danihel, PhD., doc. MUDr. Michal Mego, PhD., MUDr. Vladimír Holec, MUDr. Agáta Holecová, doc. RNDr. Vladimír Zajac, CSc., Mgr. Zuzana Adamčíková
(4/2011, Review articles ) - Treatment of advanced metastatic lung cancer in older patients
doc. MUDr. Peter Beržinec, CSc.
(5/2012, Main topic ) - Selected drug interactions in oncology
MUDr. Veronika Ballová, MUDr. Ján Rajec, PhD.
(5/2011, Review articles ) - GASTROINTESTINAL STROMAL TUMOR: A NEW ENTITY IN ONCOLOGY
MUDr. Jozef Šufliarsky
(2/2007, Review articles ) - Publikujeme v zahraničí
(5/2011, Information & comments ) - Cancer Drugs Fund – starting point or final solution to pay for innovative oncology treatment?
MUDr. Pavol Adamkov, Ing. Petra Szilágyiová, Mgr. Tomáš Pastorek
(1/2014, Main topic ) - Pharmacoeconomics and ethics in oncology: ethical dilemmas and possible solutions
Prof. MUDr. Jozef Glasa, CSc., PhD., MUDr. Helena Glasová, PhD.
(1/2014, Main topic ) - The use of immunotherapy in pediatric oncology
MUDr. Viera Bajčiová, CSc.
(1/2014, Review articles ) - Nab-technologies, nab-paclitaxel and new treatment possibilities in the treatment of selected oncology diseases
MUDr. Tomáš Šálek, MUDr. Radovan Barilla, PhD.
(4/2014, Review articles ) - Strategy of use antifungals in the treatment of oncologic patients IFD
doc. MUDr. Ľuboš Drgoňa, CSc.
(4/2014, Review articles ) - Treatment of relapsed and refractory myeloma
MUDr. Alexander Wild
(4/2013, Focus ) - New research and therapeutic targets in molecular genetics of tumors − our research potential
RNDr. Alena Gábelová, CSc., Mgr. Miroslav Chovanec, PhD., RNDr. Ján Sedlák, DrSc., Mgr. Lucia Kučerová, PhD., RNDr. Božena Smolková, PhD., Mgr. Viera Kajabová, PhD., RNDr. Ivana Fridrichová, CSc.
(1/2015, Main topic ) - Použitie rastových faktorov myelopoézy v profylaxii febrilnej neutropénie
MUDr. Juraj Chudej, PhD., MUDr. Matej Hrnčár, MUDr. Juraj Sokol, PhD., MUDr. Ivana Plameňová, PhD., MUDr. Ľubica Váleková, PhD., Prof. MUDr. Ján Staško, PhD.
(2/2018, Review articles ) - Dual inhibition after failure of NSAI as a solution to hormone therapy resistance
MUDr. Bibiána Vertáková Krakovská, PhD.
(1/2015, Review articles ) - Cardiotoxicity of drugs used in adjuvant therapy of breast cancer
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Katarína Ševčíková
(2/2009, Review articles ) - Eribulin in treatment of breast cancer
doc. MUDr. Mária Wagnerová, CSc., MUDr. Hana Garanová
(1/2015, Drugs & drug classes ) - Systemic treatment of poor prognosis germ cell tumors
MUDr. Michal Mego, PhD.
(2/2009, Review articles ) - FLT3mutácie u pacienta s AML: incidencia, možnosti diagnostiky a vplyv na manažment liečby
MUDr. Eva Mikušková, PhD., RNDr. Renata Lukačková, RNDr. Imrich Hikkel, PhD., Mgr. Michaela Zrubcová
(3/2018, Original articles & case reports ) - How are bone sarcomas seen by oncologists
MUDr. Dagmar Adámková Krákorová
(2/2011, Review articles ) - Targeted therapics for bone sarcomas
MUDr. Peter Múdry, Ph.D.
(2/2011, Review articles ) - BIOPHARMACEUTICALS IN ONCOLOGY
doc. PharmDr. Juraj Sýkora, CSc.
(3/2008, Review articles ) - Systemic therapy of biliary tract cancers
MUDr. Tomáš Šálek, MUDr. Zuzana Hlavatá, MUDr. Štefan Pörsök, PhD., MUDr. Veronika Švábová, PhD.
(3/2012, Main topic ) - Immunotherapy for lung cancer
doc. MUDr. Peter Beržinec, CSc.
(4/2016, Main topic ) - Current possibilities of immunotherapy in the treatment of malignant melanoma
MUDr. Iveta Andrezálová Vochyanová
(4/2016, Main topic ) - Stroke as a consequence of vascular toxicity induced by anticancer therapy
doc. MUDr. Beáta Mladosievičová, CSc., Mgr. Barbora Filová, MUDr. Pavol Janega, PhD.
(5/2013, Review articles ) - Complications of multiple myeloma therapy and possibilities of their influencing
MUDr. Jan Hudeček, CSc., MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD., MUDr. Ivana Plameňová, PhD.
(5/2013, Focus ) - FDA OKs bevacizumab (Avastin) for late-stage cervical cancer
doc. MUDr.Peter Beržinec, CSc.
(5/2014, Information & comments ) - Publikujeme v zahraničí
(1/2012, Information & comments ) - ABC transporters: multidrug resistance and different types of human diseases
prof. MUDr. Stanislav Špánik, CSc., doc. MUDr. Viera Lehotská, PhD., MUDr. Katarína Rauová, RNDr. Eva Weismanová, PhD., RNDr. Ľubomír Horváth, CSc., Mgr. Ján Markus, PhD., MUDr. Ladislav Sopko
(1/2012, Review articles ) - Childhood acute lymphoblastic leukemia: from genome to patient
doc. MUDr. Alexandra Kolenová, PhD.
(1/2016, Main topic ) - New possibilities and view for treatment of castration resistent prostate cancer
doc. MUDr. Igor Andrašina, CSc., MUDr. Radovan Barilla, PhD.
(1/2012, Review articles ) - Antiemetic therapy – what has brought the last decade?
MUDr. Jana Obertová
(6/2010, Review articles ) - Some Aspects of Venous Thromboembolism in Patients with Solid Tumours
MUDr. Katarína Dostálová, MUDr. Patrik Palacka, PhD.
(6/2010, Review articles ) - Nonopioid analgesics and adjuvants in treatment of cancer pain
MUDr. Miroslav Ferenčík
(1/2017, Main topic ) - The role of biomarkers in cardiotoxicity detection in childhood cancer survivors
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Dagmar Urbanová
(4/2010, Original articles & case reports ) - Psychotherapy and psychopharmacotherapy in oncology
Mgr. Lucia Vasiľková, MUDr. Katarína Tisovská
(1/2017, Review articles ) - Treatment of indolent B-cell lymphomas
MUDr. Veronika Ballová
(2/2014, Main topic ) - Comparative studies of reference biological drugs and related biological drugs
MUDr. Andrey Švec, PhD., MUDr. Marta Hájková, CSc., PharmDr. Andrea Gažová, PhD., prof. PharmDr. Ján Kyselovič, CSc.
(6/2019, Review articles ) - Alternative and complementary medicine in cancer patient
MUDr. Mária Rečková
(5/2009, Review articles ) - Initial treatment of metastatic renal cell carcinoma
MUDr. Jana Obertová, PhD.
(1/2018, Main topic ) - DID THE INTRODUCTION OF TARGETED THERAPY LIMIT THE IMPORTANCE OF CYTOSTATIC TREATMENT ?
prof. MUDr. Pavel Klener, DrSc.
(6/2007, Review articles ) - ADVANCES IN NEUROBLASTOMA DIAGNOSTICS AND TREATMENT
MUDr. Viera Bajčiová, CSc., MUDr. Pavel Mazánek, prof. MUDr. Jaroslav Šterba, PhD.,, doc. RNDr. Petr Kuglík, CSc., doc. RNDr. Renata Veselská, PhD.
(4/2008, Review articles )
- Review of of pharmacotherapy of metastatic melanoma
MUDr. Slavomír Urbanček, PhD.
(4/2016, Topic of the year )
- GASTROINTESTINAL STROMAL TUMOR: A NEW ENTITY IN ONCOLOGY
MUDr. Jozef Šufliarsky
(2/2007, clearly )
- Biological drugs from the perspective of pharmacy
PharmDr. Katarína Bruchatá, PhD., Mgr. Peter Heinz
(4/2014, Pharmaceutical technology )
- Some Aspects of Venous Thromboembolism in Patients with Solid Tumours
MUDr. Katarína Dostálová, MUDr. Patrik Palacka, PhD.
(3/2011, Review articles ) - Biosimilars – generic copies of various types of biotech drugs?
doc. MUDr. Ján Staško, PhD., prof. MUDr. Peter Kubisz, DrSc., MUDr. Juraj Chudej, PhD., MUDr. Pavol Hollý, PhD., MUDr. Juraj Sokol, PhD.
(1/2015, Review articles )